Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(l-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent. - Fujita,T.; Sugiyama,Y.; Taketomi,S.; Sohda,T.; Kawamatsu,Y.; Iwatsuka,H.; Suzuoki,Z. (Diabetes, 1983)